Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Illumina Laboratory Services, |
RCV000367434 | SCV000448741 | uncertain significance | Aspartylglucosaminuria | 2016-06-14 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000367434 | SCV000755892 | benign | Aspartylglucosaminuria | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002356480 | SCV002658087 | likely benign | Inborn genetic diseases | 2022-03-07 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Natera, |
RCV000367434 | SCV001457095 | benign | Aspartylglucosaminuria | 2020-09-16 | no assertion criteria provided | clinical testing |